Holen Sie sich die Stockscreener-App
1.12
2.61%
-0.03
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
15.20%
6.406
|
5.561 | 4.349 | 5.604 | 4.015 |
| Cost Of Revenue |
13.28%
3.829
|
3.38 | 2.699 | 3.484 | 2.551 |
| Gross Profit |
18.16%
2.577
|
2.181 | 1.65 | 2.12 | 1.464 |
Operating Expenses
|
3.36%
2.617
|
2.532 | 2.328 | 2.457 | 2.559 |
| Operating Income/Loss |
88.60%
-0.04
|
-0.351 | -0.678 | -0.337 | -1.095 |
| Income/Loss From Continuing Operations Before Tax |
33.60%
-0.33
|
-0.497 | -0.949 | -0.731 | -1.242 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.084 | -0.13 | -0.197 | -0.001 |
| Net Income/Loss |
43.20%
-0.33
|
-0.581 | -0.819 | -0.534 | -1.241 |
| Basic Average Shares |
3.846
|
- | 1.713 | 1.646 | 1.641 |
| Diluted Average Shares |
3.846
|
- | 1.713 | 1.646 | 1.641 |
| Basic Earnings Per Share |
-0.09
|
- | -0.48 | -0.32 | -0.76 |
| Diluted Earnings Per Share |
-0.09
|
- | -0.48 | -0.32 | -0.76 |
3.58%
7.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):